Companies begin to focus on insulin pens

06/5/2007 | Wall Street Journal, The

Insulin pens haven't been a huge success in the U.S., but manufacturers are hoping that more-attractive devices, better sales pitches and an offer of discounts will change that. Eli Lilly plans to launch three new pens this year, including a burgundy digital pen, and Sanofi-Aventis has created a disposable pen that it plans to market directly to consumers.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ